Calcium, a vital mineral, plays a crucial role in various physiological processes, including bone metabolism. This article aims to provide an in-depth understanding of the integral role of calcium in bone metabolism.
Calcium is the primary component of hydroxyapatite, the mineral complex that gives strength and rigidity to bones and teeth. It constitutes about 99% of the body's total calcium, signifying its critical role in maintaining structural integrity.
Bone metabolism involves two main processes - bone formation and bone resorption. Osteoblasts, the cells responsible for bone formation, require calcium for the synthesis of bone matrix. Conversely, osteoclasts, the cells responsible for bone resorption, release calcium from the bones into the bloodstream. Thus, calcium plays a dual role in bone metabolism.
Calcium homeostasis is tightly regulated by hormones such as parathyroid hormone (PTH), calcitonin, and vitamin D. PTH and vitamin D increase blood calcium levels, while calcitonin decreases it. Any imbalance in these hormones can lead to disorders like osteoporosis or hypercalcemia.
Appropriate calcium intake is vital for optimal bone health. While dietary sources are preferred, calcium supplementation can be beneficial for individuals with inadequate dietary intake or increased requirements. However, excessive supplementation can lead to hypercalcemia and renal stones, emphasizing the need for medical supervision.
Understanding the role of calcium in bone metabolism is essential for healthcare professionals. It aids in the prevention, diagnosis, and treatment of bone-related disorders. Therefore, ensuring adequate calcium intake and maintaining calcium homeostasis should be integral parts of patient care.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation